Sanofi Genzyme and Regeneron are committed to researching ways to address the needs of patients with moderate-to-severe asthma and other serious and debilitating diseases. We aim to explore the science behind Type 2 immune disease and options for patients with uncontrolled persistent asthma. That’s why we are working with healthcare professionals to broaden awareness of Type 2 asthma.
For UK Healthcare Professionals Only
404 Not Found
Sorry, the page you are looking for is not found !